Edition:
United States

People: Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

113.19USD
2:56pm EST
Change (% chg)

$-0.83 (-0.73%)
Prev Close
$114.02
Open
$114.82
Day's High
$114.82
Day's Low
$112.91
Volume
146,289
Avg. Vol
499,709
52-wk High
$132.95
52-wk Low
$67.81

Termeer, Henri 

Mr. Henri A. Termeer is an Independent Director of Abiomed, Inc., Prior to Genzyme Corporation’s acquisition in April 2011 by Sanofi, Mr. Termeer had been the President, and a director of Genzyme Corporation since 1983, its Chief Executive Officer since 1985 and its Chairman since 1988. Mr. Termeer is a member of the Board of Directors of the Massachusetts Institute of Technology, Massachusetts General Hospital and Partners HealthCare. Mr. Termeer is a member of the Board of Fellows of Harvard Medical School. He is also the Chairman of the Board of Aveo Pharmaceuticals and member of the Board of Directors of Verastem, Inc. Mr. Termeer served as the Deputy Chairman of the Federal Reserve Bank of Boston from 2007 to 2009 and as its Chairman from 2010 through the end of 2011. Mr. Termeer studied economics at the Economische Hogeschool at Erasmus University in The Netherlands and received his Master of Business Administration from the Darden School of Business at the University of Virginia.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Minogue

19,021,900

Michael Tomsicek

2,940,890

David Weber

5,448,190

William Bolt

1,588,680

Andrew Greenfield

536,074

Michael Howley

1,606,930
As Of  30 Mar 2016